Buison Anne, Pellizzon Michael, Ordiz Frank, Jen K-L Catherine
Department of Nutrition and Food Science, Wayne State University, Detroit, MI, USA.
Metabolism. 2004 Jun;53(6):782-9. doi: 10.1016/j.metabol.2003.12.022.
The current study sought to examine whether leptin injections following a weight reduction in diet-induced obese rats would reduce both the enhanced food intake and body weight (BW) regain observed during the refeeding phase. Female Wistar rats (n = 100, 20 per group) were divided into 5 groups: (1) LEP rats were fed a high-fat (HF) diet (35% wt/wt) for 8 weeks to induce obesity and were then food-restricted (50% ad libitum) with a fortified high-fat diet for 2 weeks to induce a 20% BW loss. These rats were then refed the HF diet ad libtum for another 11 weeks. They were given leptin injections (200 microg/kg BW, twice daily, intraperitoneally ) for 19 days concomitant with the onset of refeeding. (2) SAL rats were treated in the same manner as LEP rats except that they were given saline injections; (3) PF rats were treated like SAL rats except that they were pair-fed with the LEP rats; (4) HFC rats were fed HF diet ad libitum; and (5) LFC rats were fed a low-fat (LF) diet (AIN-93M) ad libitum. Ten rats from each group were killed after leptin treatment and at the end of the study. Food and caloric intakes were monitored, and body composition and plasma glucose, insulin, and leptin levels were assessed at death. Leptin injections after a weight reduction briefly reduced energy intake during the first week only. After 19 days of treatment and to the end of the study, LEP and SAL rats were similar in energy intake, BW (LEP: 393 +/- 11.2 g, SAL: 371 +/- 14.1; difference not significant [NS]) and total body fat percent (LEP: 19.3 +/- 1.5, SAL: 17.6 +/- 1.5; NS). Leptin treatment induced hyperinsulinemia and insulin resistance. All of the metabolic abnormalities observed at the end of treatment period disappeared at the end of the study (8 weeks post-leptin injection). We conclude that bolus leptin injections to manipulate leptin circadian rhythm in diet-induced obese rats after a weight reduction caused temporary insulin resistance and hyperinsulinemia, and were ineffective in influencing food intake, BW, and fat content. Leptin resistance was evident following 1 week of treatment in this study. Leptin treatment had no effect on body fat content both short-term and long-term. Exogenous leptin treatment may, in the long run, increase leptin resistance in diet-induced obese animals. Hence, long-term leptin treatment may not be beneficial to obese individuals consuming a HF diet.
当前研究旨在探究在饮食诱导的肥胖大鼠体重减轻后注射瘦素,是否会减少在重新喂食阶段观察到的食物摄入量增加和体重(BW)反弹。将雌性Wistar大鼠(n = 100,每组20只)分为5组:(1)LEP组大鼠喂食高脂(HF)饮食(35% wt/wt)8周以诱导肥胖,然后用强化高脂饮食限制食物摄入量(自由摄入量的50%)2周以诱导体重减轻20%。然后这些大鼠再次自由进食HF饮食11周。在重新喂食开始时,它们接受瘦素注射(200 μg/kg BW,每日两次,腹腔内注射)19天。(2)SAL组大鼠的处理方式与LEP组大鼠相同,只是它们接受生理盐水注射;(3)PF组大鼠的处理方式与SAL组大鼠相同,只是它们与LEP组大鼠配对喂食;(4)HFC组大鼠自由进食HF饮食;(5)LFC组大鼠自由进食低脂(LF)饮食(AIN - 93M)。在瘦素治疗后以及研究结束时,每组处死10只大鼠。监测食物和热量摄入量,并在处死时评估身体组成以及血浆葡萄糖、胰岛素和瘦素水平。体重减轻后注射瘦素仅在第一周短暂减少了能量摄入。治疗19天后直至研究结束,LEP组和SAL组大鼠在能量摄入、体重(LEP组:393±11.2 g,SAL组:371±14.1;差异无统计学意义[NS])和全身脂肪百分比(LEP组:19.3±1.5,SAL组:17.6±1.5;NS)方面相似。瘦素治疗诱导了高胰岛素血症和胰岛素抵抗。在治疗期结束时观察到的所有代谢异常在研究结束时(瘦素注射后8周)消失。我们得出结论,在饮食诱导的肥胖大鼠体重减轻后,注射大剂量瘦素以操纵瘦素昼夜节律会导致暂时的胰岛素抵抗和高胰岛素血症,并且在影响食物摄入量、体重和脂肪含量方面无效。在本研究中,治疗1周后瘦素抵抗明显。瘦素治疗在短期和长期对身体脂肪含量均无影响。从长远来看,外源性瘦素治疗可能会增加饮食诱导的肥胖动物的瘦素抵抗。因此,长期瘦素治疗可能对食用HF饮食的肥胖个体无益处。